“Secukinumab Sustains Individual Clinical Responses Over Time in Patients With Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S21. https://doi.org/10.25251/skin.2.supp.21.